IDH1 and central nervous system cancer: With assistance of the ratiometric SERS nanoprobe and the deep learning algorithm, we can intraoperatively identify IDH1 mutation status of glioma patients by soaking freshly excised glioma tissue in the aqueous solution of the nanoprobe, followed by point‐by‐point Raman signal acquisition on the tissue block surface.